CraigDanielSeamanMD

Hematology • Pittsburgh, PA

Clotting Disorder, Hemophilia & Bleeding Disorder

Assistant Professor of Medicine

Join to view full profile

Dr. Seaman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Seaman's full profile

Already have an account?

Office
3636 Boulevard of the Allies
Pittsburgh, PA 15213
Phone+1 412-209-7280

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2011 - 2014
UPMC Medical EducationResidency, Internal Medicine, 2008 - 2011
Marshall University Joan C. Edwards School of MedicineClass of 2008

Certifications & Licensure

PA State Medical License 2008 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Clinical Trials

Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome Start of enrollment: 2014 May 01
Terminated
Phase 2
Weight-based Dosing in Hemophilia A Start of enrollment: 2015 Sep 01
Terminated
Phase 2

Publications & Presentations

PubMed

35 citations
Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register
Craig D. Seaman, Jonathan Yabes, Diane M. Comer, Margaret V. Ragni
Journal of Thrombosis and Haemostasis. 2015-11-01
33 citations
Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis.
Craig D. Seaman, Jonathan Yabes, Jie Li, Charity G. Moore, Margaret V. Ragni
Thrombosis Research. 2014-12-01
3 citations
Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome
Craig D. Seaman, Enrico M. Novelli, Laura M. De Castro, Margaret V. Ragni
Pilot and Feasibility Studies. 2020-11-10

Abstracts/Posters

Emicizumab Prophylaxis in Patients with Hemophilia _ with and without Inhibitors
Craig D. Seaman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
Craig D. Seaman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019